Inventor · disambiguated record
Isabelle Orly
Also filed as: ORLY ISABELLE
5 granted patents·8 pending applications·277 citations·filing 1993–2015
82Inventor score
Files withCOLETICA4BASF BEAUTY CARE SOLUTIONS F3BOUEZ CHARBEL2BASF BEAUTY CARE SOLUTIONS FRANCE S A S1BECHETOILLE NICOLAS1
Top patents by PatentIndex Score
13 records- 0188US5672301AMethod for fabricating microparticles in emulsion by modification of the chemical composition of the dispersed phase after emulsificationCOLETICA·Filed 1993·Granted Sep 30, 1997·71 cites·72 claims
- 0282US5635609AParticles prepared by transacylation reaction between an esterified polysaccharide and a polyamine, methods of preparation therefor and compositions containing sameCOLETICA·Filed 1994·Granted Jun 3, 1997·91 cites·49 claims
- 0368US5658593AInjectable compositions containing collagen microcapsulesCOLETICA·Filed 1996·Granted Aug 19, 1997·115 cites·58 claims
- 0451US2010209407A1Mc-1r, mc-2r, and/or mu opioid receptors modulationBASF BEAUTY CARE SOLUTIONS F·Filed 2008·Application pending·0 cites
- 0551US2010272699A1MC-1R, MC-2R, and/or µ OPIOID RECEPTORS STIMULATIONBASF BEAUTY CARE SOLUTIONS F·Filed 2008·Application pending·0 cites
- 0650US2009081783A1Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytesBECHETOILLE NICOLAS·Filed 2007·Application pending·0 cites
- 0749US2004258676A1Stimulation of the activity of an isoform of lysyl oxidase for combating against some pathologies due to an incomplete, absent or disorganized elastogenesisCOLETICA·Filed 2004·Application pending·0 cites
- 0848US9925134B2Use of substances to protect FGF-2 or FGF-beta growth factorRIVAL DELPHINE·Filed 2007·Granted Mar 27, 2018·0 cites·16 claims
- 0946US9308161B2Substance for restoring normal co-expression and interaction between the LOX and NRAGE proteinsBOUEZ CHARBEL·Filed 2012·Granted Apr 12, 2016·0 cites·17 claims
- 1046US2011223264A1Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE ProteinsBOUEZ CHARBEL·Filed 2006·Application pending·0 cites
- 1141US2016095815A1Substance for restoring normal co-expression and interaction between the lox and nrage proteinsBASF BEAUTY CARE SOLUTIONS F·Filed 2015·Application pending·0 cites
- 1238US2010297765A1Method for producing langerhans cells or interstitial dendritic cells or both from cd14+ monocytesBASF BEAUTY CARE SOLUTIONS FRANCE S A S·Filed 2010·Application pending·0 cites
- 1336US2005008623A1In vitro production of dendritic cells from CD14+ monocytesFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →